2024 Code Clause 10.4 Q&As
Now published
The Prescription Medicines Code of Practice Authority
The Prescription Medicines Code of Practice Authority The Prescription Medicines Code of Practice Authority (PMCPA) is the self-regulatory body which administers the Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry, independently of the ABPI. It was established by the ABPI on 1 January 1993. The Authority is responsible for the provision of advice, guidance and training on the Code as well as for the complaints procedure. It is also responsible for arranging for conciliation between companies when requested to do so and for arranging for the scrutiny of advertising and meetings on a regular basis.
Training
-
PMCPA learning portal
PMCPA learning portal
Three on-demand webinars explaining the changes in the 2024 ABPI Code:
- Introduction to the 2024 Code
- Changes to the 2024 Code
- Changes to the PMCPA Constitution and ProcedureAnd an interactive e-learning module targeted at individuals requiring an overview of the ABPI Code.
-
Examinations
The representative examinations
In relation to extensions to the time period to take and pass the ABPI Advanced Programme for Industry Personnel (previously called ABPI Medical Representatives Examination) and the ABPI Intermediate Programme for Industry Personnel (previously called ABPI Generic Sales Representatives Examination) please check the following link
-
ABPI Code Of Practice training
Two new November 2024 full day ABPI Code Of Practice training days at a central London location are now available to book
The training will cover the requirements of the Code of Practice and procedures followed by the PMCPA - Fully Booked
The Appeal Board can impose additional sanctions in cases where: the Appeal Board rules a breach of the Code, or a breach of the Code has been accepted by the Company at the Panel level, or the Panel reports a Company to the Appeal Board.
Corrective Statements, Public Reprimands and Advertisements (from May 2011 onwards) can be accessed below. Details of Audits, Re-Audits and the Recovery of items are included in the individual case reports.
The PMCPA advertises brief details of all cases where companies are ruled in breach of Clause 2 of the Code, are required to issue a corrective statement or are the subject of a public reprimand in the medical and pharmaceutical press: the British Medical Journal and the Nursing Standard.
Advertised Sanctions
Cases
Complaints considered by the Code of Practice Panel are judged on the evidence provided by both parties. Once concluded a case report is published on this website. Good compliance decisions rely on both the interpretation of the Code and an understanding of its application, published case reports help in this regard and set precedent in a particular set of circumstances. When making decisions on compliance with the Code, knowledge gained from previous case reports can be beneficial.
Completed cases are published here
Completed cases
